Abstract: A novel immunodeficiency virus is disclosed which has the designation MVP-5180/91 and which has been deposited with the European Collection of Animal Cell Cultures (ECACC) under No. V 920 52 318. The characteristic antigens which can be obtained from it and which can be employed for detecting antibodies against retroviruses which are associated with immunodeficiency diseases are also disclosed, as are the DNA and amino acid sequences of the virus.

Abstract: A novel immunodeficiency virus is disclosed which has the designation MVP-5180/91 and which has been deposited with the European Collection of Animal Cell Cultures (ECACC) under No. V 920 52 318. The characteristic antigens which can be obtained from it and which can be employed for detecting antibodies against retroviruses which are associated with immunodeficiency diseases are also disclosed, as are the DNA and amino acid sequences of the virus.

Abstract: A novel immunodeficiency virus is disclosed which has the designation MVP-5180/91 and which has been deposited with the European Collection of Animal Cell Cultures (ECACC) under No. V 920 52 318. The characteristics antigens which can be obtained from it and which can be employed for detecting antibodies against retroviruses which are associated with immunodeficiency diseases are also disclosed, as are the DNA and amino acid sequences of the virus.

Abstract: The present invention relates to immunoreactive peptides that are homologous with the region encompassing amino acid positions 450 to 655 of glycoprotein II of varicella zoster virus. In this context, preference is given to those peptides corresponding to segments of amino acids 505 to 647, 517 to 597, 535 to 584 or 545 to 582. The immunoreactive peptides are useful for methods of diagnosing varicella zoster virus infection.

Abstract: The present invention relates to immunoreactive peptides that are homologous with the region encompassing amino acid positions 450 to 655 of glycoprotein II of varicella zoster virus. In this context, preference is given to those peptides corresponding to segments of amino acids 505 to 647, 517 to 597, 535 to 584 or 545 to 582. The immunoreactive peptides are useful for methods of diagnosing varicella zoster virus infection.

Abstract: The invention relates to human procalcitonin and the preparation and use thereof. In particular, a process for preparing human procalcitonin is described wherein a gene coding for a polypeptide comprising the amino acid sequence of human procalcitonin is inserted into a vector; a host organism is transformed with this gene-containing vector; and the polypeptide expressed by the host organism is isolated. Furthermore the use of the polypeptides according to the invention, in particular as medicaments and diagnostic agents is described.

Abstract: A novel immunodeficiency virus is disclosed which has the designation MVP-5180/91 and which has been deposited with the European Collection of Animal Cell Cultures (ECACC) under No. V 920 92 318. The characteristic antigens which can be obtained from it and which can be employed for detecting antibodies against retroviruses which are associated with immuno-deficiency diseases are also disclosed, as are the DNA and amino acid sequences of the virus.

Abstract: Varicella zoster virus (VZV) immunoreactive protein VP26 and its diagnostic use are described. The invention relates to immunoreactive peptides which are homologous with the region of amino acid positions 12 to 235 of the varicella zoster virus protein VP26, to nucleic acids which encode these peptides and to the use of the peptides or nucleic acids for diagnosing an infection with varicella zoster virus.

Abstract: A novel immunodeficiency virus is disclosed which has the designation MVP-2901/94 and which has been deposited with the European Collection of Animal Cell Cultures (ECACC) under No. V 95012601. The characteristic antigens which can be obtained from the virus and which can be employed for detecting antibodies against retroviruses which are associated with immunodeficiency diseases are also disclosed, as are the partial DNA and amino acid sequences of the virus.

Abstract: A method is described for the reading of a bar code consisting of a predetermined number of code elements for the production of a binary signal with sequential high and low phases the length of which correspond to the width of the sequential code elements. In the method the code elements are scanned by the scanning beam or by a plurality of scanning beams of a bar code reader along scanning lines extending substantial parallel to one another. During this the sweeping of the scanning beam over the bar code defines a scan and a scanning plane is defined by each scanning beam when sweeping over the bar code. The angle of tilt between the respective scanning plane and A predetermined reference plane is determined for essentially each scan. During the decoding of the bar code the angles of tilt thus found are evaluated to compensate for grid errors, i.e. for irregular spacings between adjacent scanning lines.

Abstract: The present invention is directed to an immunochemical method for qualitatively or quantitatively detecting an analyte in which a first and a second binding component are contacted with the analyte, followed by detection of the binding of the binding components to the analyte. According to the invention, both of the binding components are prepared recombinantly in the same host using different vectors (V1 and V2) for expressing fusion proteins, with the first binding component being expressed as a fusion protein F1 in vector V1 and the second binding component being expressed as a fusion protein F2 in vector V2. The novel method, which can also be employed for simultaneously determining several analytes, is more sensitive and specific than prior known methods.

Abstract: A method is described for the reading of a bar code consisting of a predetermined number of code elements for the generation of a binary signal with sequential high and low phases, the lengths of which correspond to the width of the sequential code elements, in particular with a reading direction extending obliquely to the code elements. The code elements are sensed by one or more sensing beams of a bar code reader along scanning lines extending substantially parallel to one another, with each region of a code element scanned by a scanning line forming a code element section. For substantially each scanning line those code segments which consist of a code element section, or a plurality of sequential code element sections, are detected, which are recognized as permissible code segments on the basis of preset decision criteria.

Abstract: A novel immunodeficiency virus is disclosed which has the designation MVP-5180/91 (SEQ ID NO:56) and which has been deposited with the European Collection of Animal Cell Cultures (ECACC) under No. V 920 92 318. The characteristic antigens which can be obtained from it and which can be employed for detecting antibodies against retroviruses which are associated with immuno-deficiency diseases are also disclosed, as are the DNA and amino acid sequences of the virus.

Abstract: A novel HIV type O immunodeficiency virus is disclosed which has the designation MVP-2901/94 and which has been deposited with the European Collection of Animal Cell Cultures (ECACC) under No. V 95012601. The characteristic antigens which can be obtained from the virus and which can be employed for detecting antibodies against retroviruses which are associated with immunodeficiency diseases are also disclosed, as are the partial DNA and amino acid sequences of the virus.

Abstract: A novel immunodeficiency virus is disclosed which has the designation MVP-5180/91 (SEQ ID NO:56) and which has been deposited with the European Collection of Animal Cell Cultures (ECACC) under No. V 920 92 318. The characteristic antigens which can be obtained from it and which can be employed for detecting antibodies against retroviruses which are associated with immunodeficiency diseases are also disclosed, as are the DNA and amino acid sequences of the virus.

Abstract: A novel immunodeficiency virus is disclosed which has the designation MVP-5180/91 (SEQ ID NO:56) and which has been deposited with the European Collection of Animal Cell Cultures (ECACC) under No. V 920 92 318. The characteristic antigens which can be obtained from it and which can be employed for detecting antibodies against retroviruses which are associated with immunodeficiency diseases are also disclosed, as are the DNA and amino acid sequences of the virus.

Abstract: A lighting and flash device comprises a flash tube with a corresponding ignition device and at least two energy storage device units. The voltage of the energy storage device units is independently adjustable. When the voltage of the energy storage device units is accordingly divided, the resulting color temperature, in practice, is held relatively constant within allowable limits.

Abstract: A stationary container equipped with an inlet and an outlet and filled with grinding medium encloses a drivable, rotatably mounted stirrer whose active surfaces are formed as impellers for the grinding medium which are closely adjacent to the inner surface of the container.

Abstract: An optical recording medium contains a transparent base, a dye-containing layer which is sensitive to laser light and a reflector layer which contains a silicon-phthalocyanine derivative of the formula ##STR1## where R.sup.1 is hydrogen, alkyl, alkoxy, halogen or trialkylsilyl, n is 1, 2, 3 or 4 and A and B are identical or different and independently of one another are each alkyl, halogen or unsubstituted or substituted alkoxy or trialkylsilyloxy.

Abstract: A tetrachloroperylene-3,4,9,10-tetracarboxylic acid diimide pigment which contains not less than 85% by weight of the tetrachloro compound of the formula ##STR1## which is present to the extent of not less than 95% by weight in the .beta.-modification and which, in an X-ray spectrum, exhibits 2.sup..crclbar. CuK.sub..alpha. main lines at 9.0.degree., 13.3.degree., 15.0.degree., 16.8.degree., 19.1.degree., 21.5.degree., 24.2.degree., 25.4.degree., 26.5.degree., 27.0.degree. and 27.5.degree..In finishes, the pigment gives very brilliant colorations which are very highly lightfast and fast to weathering and which, upon weathering, neither bleach nor darken up.